Cargando…

Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity

OBJECTIVE: Metabolic inflammation is believed to promote insulin resistance and type 2 diabetes progression in obesity. TRAF3, a cytoplasmic signaling protein, has been known to mediate/modulate cytokine signaling in immune cells. The goal is to define the metabolic function of hepatic TRAF3 in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zheng, Canet, Mark J., Sheng, Liang, Jiang, Lin, Xiong, Yi, Yin, Lei, Rui, Liangyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731737/
https://www.ncbi.nlm.nih.gov/pubmed/26909311
http://dx.doi.org/10.1016/j.molmet.2015.09.013
_version_ 1782412580079271936
author Chen, Zheng
Canet, Mark J.
Sheng, Liang
Jiang, Lin
Xiong, Yi
Yin, Lei
Rui, Liangyou
author_facet Chen, Zheng
Canet, Mark J.
Sheng, Liang
Jiang, Lin
Xiong, Yi
Yin, Lei
Rui, Liangyou
author_sort Chen, Zheng
collection PubMed
description OBJECTIVE: Metabolic inflammation is believed to promote insulin resistance and type 2 diabetes progression in obesity. TRAF3, a cytoplasmic signaling protein, has been known to mediate/modulate cytokine signaling in immune cells. The goal is to define the metabolic function of hepatic TRAF3 in the setting of obesity. METHODS: Hepatocyte-specific TRAF3 knockout mice were generated using the loxp/albumin-cre system. Liver TRAF3 was deleted in adult obese mice via Cre adenoviral infection. Both high fat diet-induced and genetic obesity were examined. TRAF3 levels and insulin signaling were measured by immunoblotting. Insulin sensitivity, hepatic glucose production, and glucose metabolism were examined by glucose, insulin, and pyruvate tolerance tests. Hepatic steatosis was examined by Oil red O staining of liver sections and measuring liver triacylglycerol levels. RESULTS: Liver TRAF3 levels were lower in the fasted states in normal mice, and were aberrantly higher in obese mice and in mice with streptozotocin-induced hyperglycemia. Glucose directly increased TRAF3 levels in primary hepatocytes. Hepatocyte-specific deletion of TRAF3 decreased hyperinsulinemia, insulin resistance, glucose intolerance, and hepatic steatosis in mice with either high fat diet-induced obesity or genetic obesity (ob/ob); conversely, in lean mice, adenovirus-mediated overexpression of TRAF3 in the liver induced hyperinsulinemia, insulin resistance, and glucose intolerance. Deletion of TRAF3 enhanced the ability of insulin to stimulate phosphorylation of Akt in hepatocytes, whereas overexpression of TRAF3 suppressed insulin signaling. CONCLUSIONS: Glucose increases the levels of hepatic TRAF3. TRAF3 in turn promotes hyperglycemia through increasing hepatic glucose production, thus forming a glucose-TRAF3 reinforcement loop in the liver. This positive feedback loop may drive the progression of type 2 diabetes and nonalcoholic fatty liver disease in obesity.
format Online
Article
Text
id pubmed-4731737
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47317372016-02-23 Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity Chen, Zheng Canet, Mark J. Sheng, Liang Jiang, Lin Xiong, Yi Yin, Lei Rui, Liangyou Mol Metab Original Article OBJECTIVE: Metabolic inflammation is believed to promote insulin resistance and type 2 diabetes progression in obesity. TRAF3, a cytoplasmic signaling protein, has been known to mediate/modulate cytokine signaling in immune cells. The goal is to define the metabolic function of hepatic TRAF3 in the setting of obesity. METHODS: Hepatocyte-specific TRAF3 knockout mice were generated using the loxp/albumin-cre system. Liver TRAF3 was deleted in adult obese mice via Cre adenoviral infection. Both high fat diet-induced and genetic obesity were examined. TRAF3 levels and insulin signaling were measured by immunoblotting. Insulin sensitivity, hepatic glucose production, and glucose metabolism were examined by glucose, insulin, and pyruvate tolerance tests. Hepatic steatosis was examined by Oil red O staining of liver sections and measuring liver triacylglycerol levels. RESULTS: Liver TRAF3 levels were lower in the fasted states in normal mice, and were aberrantly higher in obese mice and in mice with streptozotocin-induced hyperglycemia. Glucose directly increased TRAF3 levels in primary hepatocytes. Hepatocyte-specific deletion of TRAF3 decreased hyperinsulinemia, insulin resistance, glucose intolerance, and hepatic steatosis in mice with either high fat diet-induced obesity or genetic obesity (ob/ob); conversely, in lean mice, adenovirus-mediated overexpression of TRAF3 in the liver induced hyperinsulinemia, insulin resistance, and glucose intolerance. Deletion of TRAF3 enhanced the ability of insulin to stimulate phosphorylation of Akt in hepatocytes, whereas overexpression of TRAF3 suppressed insulin signaling. CONCLUSIONS: Glucose increases the levels of hepatic TRAF3. TRAF3 in turn promotes hyperglycemia through increasing hepatic glucose production, thus forming a glucose-TRAF3 reinforcement loop in the liver. This positive feedback loop may drive the progression of type 2 diabetes and nonalcoholic fatty liver disease in obesity. Elsevier 2015-10-17 /pmc/articles/PMC4731737/ /pubmed/26909311 http://dx.doi.org/10.1016/j.molmet.2015.09.013 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chen, Zheng
Canet, Mark J.
Sheng, Liang
Jiang, Lin
Xiong, Yi
Yin, Lei
Rui, Liangyou
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title_full Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title_fullStr Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title_full_unstemmed Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title_short Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
title_sort hepatocyte traf3 promotes insulin resistance and type 2 diabetes in mice with obesity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731737/
https://www.ncbi.nlm.nih.gov/pubmed/26909311
http://dx.doi.org/10.1016/j.molmet.2015.09.013
work_keys_str_mv AT chenzheng hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT canetmarkj hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT shengliang hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT jianglin hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT xiongyi hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT yinlei hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity
AT ruiliangyou hepatocytetraf3promotesinsulinresistanceandtype2diabetesinmicewithobesity